FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3083561806> ?p ?o ?g. }

• W3083561806 abstract "Membranes are unique phospholipid (PL) interfaces that play a central role in cancer cell biology. However, PL composition of clinical tumors, and its dynamic regulation, remains a critical gap in the molecular profiling of this disease. Here, we used mass spectrometry-based spatial imaging and lipidomics to generate PL profiles of clinical prostate tissues upon cancer development and in patient-derived tumor explants (PDEs; n=43) cultured with the current clinical agent enzalutamide. Analysis of more than 100 PL species in tumors and matched normal tissues from 21 patients revealed a complexity of cancer-related changes in the tissue PL landscape. Phosphatidylcholine (PC)-based PLs were the most abundant PL class, and their relative abundance was increased in tumors compared to matched benign tissues. A greater proportion of monounsaturated fatty acid chains was characteristic of PLs in tumors, most evident in the PC and phosphatidylethanolamine (PE) PLs, as was striking elongation of fatty acid chains in the phosphatidylinositol (PI) and phosphatidylserine (PS) classes. The abundance of specific PL species and saturation groups was significantly associated with malignancy in both this and an independent cohort of unmatched patient tissues (n=47). Notably, the PL profile was significantly associated with the ERG molecular subtype and basal proliferative index (Ki67) in tumors. Furthermore, we identified individual PL species that were associated with the antiproliferative response to enzalutamide, in cultured PDEs. In light of these PL features, we proposed acetyl coA carboxylase (ACC) as a novel therapeutic target in prostate cancer. Indeed, blocking lipid biosynthesis and elongation in prostate tumors with an ACC inhibitor (ACCi, PF-05175157) significantly reduced tumor cell proliferation in PDE tissues (n=13), concomitant with increased pACC1 staining and a decreased proportion of longer chain PLs. Our findings suggest that the clinical PCa lipidome is not only a marker of malignant transformation and aggressiveness, but also therapeutic response to enzalutamide. Moreover, defining this unique biology identified further clinically actionable targets that may improve prostate cancer outcomes. Citation Format: Lisa M. Butler, Chui Yan Mah, Jonas Dehairs, Andrew Vincent, Shadrack Mutuku, Xander Spotbeen, Rajdeep Das, Zeyad Nassar, Luke Selth, Paul Trim, Marten Snel, David Lynn, Lisa Horvath, Wayne Tilley, Margaret Centenera, Johannes Swinnen. Phospholipid profiling of clinical prostate tissues reveals targetable alterations in membrane lipid composition accompanying tumorigenesis [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 2076." @default.
• W3083561806 created "2020-09-11" @default.
• W3083561806 creator A5010847260 @default.
• W3083561806 creator A5016018766 @default.
• W3083561806 creator A5020285542 @default.
• W3083561806 creator A5023698490 @default.
• W3083561806 creator A5026099102 @default.
• W3083561806 creator A5032847871 @default.
• W3083561806 creator A5040319024 @default.
• W3083561806 creator A5043562354 @default.
• W3083561806 creator A5047928354 @default.
• W3083561806 creator A5050075947 @default.
• W3083561806 creator A5051262301 @default.
• W3083561806 creator A5056324208 @default.
• W3083561806 creator A5078810319 @default.
• W3083561806 creator A5080276064 @default.
• W3083561806 creator A5084855225 @default.
• W3083561806 creator A5091582733 @default.
• W3083561806 date "2020-08-13" @default.
• W3083561806 modified "2023-10-14" @default.
• W3083561806 title "Abstract 2076: Phospholipid profiling of clinical prostate tissues reveals targetable alterations in membrane lipid composition accompanying tumorigenesis" @default.
• W3083561806 doi "https://doi.org/10.1158/1538-7445.am2020-2076" @default.
• W3083561806 hasPublicationYear "2020" @default.
• W3083561806 type Work @default.
• W3083561806 sameAs 3083561806 @default.
• W3083561806 citedByCount "0" @default.
• W3083561806 crossrefType "proceedings-article" @default.
• W3083561806 hasAuthorship W3083561806A5010847260 @default.
• W3083561806 hasAuthorship W3083561806A5016018766 @default.
• W3083561806 hasAuthorship W3083561806A5020285542 @default.
• W3083561806 hasAuthorship W3083561806A5023698490 @default.
• W3083561806 hasAuthorship W3083561806A5026099102 @default.
• W3083561806 hasAuthorship W3083561806A5032847871 @default.
• W3083561806 hasAuthorship W3083561806A5040319024 @default.
• W3083561806 hasAuthorship W3083561806A5043562354 @default.
• W3083561806 hasAuthorship W3083561806A5047928354 @default.
• W3083561806 hasAuthorship W3083561806A5050075947 @default.
• W3083561806 hasAuthorship W3083561806A5051262301 @default.
• W3083561806 hasAuthorship W3083561806A5056324208 @default.
• W3083561806 hasAuthorship W3083561806A5078810319 @default.
• W3083561806 hasAuthorship W3083561806A5080276064 @default.
• W3083561806 hasAuthorship W3083561806A5084855225 @default.
• W3083561806 hasAuthorship W3083561806A5091582733 @default.
• W3083561806 hasConcept C104317684 @default.
• W3083561806 hasConcept C111919701 @default.
• W3083561806 hasConcept C121608353 @default.
• W3083561806 hasConcept C126322002 @default.
• W3083561806 hasConcept C185592680 @default.
• W3083561806 hasConcept C187191949 @default.
• W3083561806 hasConcept C2776235491 @default.
• W3083561806 hasConcept C2778918659 @default.
• W3083561806 hasConcept C41008148 @default.
• W3083561806 hasConcept C41625074 @default.
• W3083561806 hasConcept C502942594 @default.
• W3083561806 hasConcept C55493867 @default.
• W3083561806 hasConcept C555283112 @default.
• W3083561806 hasConcept C71924100 @default.
• W3083561806 hasConceptScore W3083561806C104317684 @default.
• W3083561806 hasConceptScore W3083561806C111919701 @default.
• W3083561806 hasConceptScore W3083561806C121608353 @default.
• W3083561806 hasConceptScore W3083561806C126322002 @default.
• W3083561806 hasConceptScore W3083561806C185592680 @default.
• W3083561806 hasConceptScore W3083561806C187191949 @default.
• W3083561806 hasConceptScore W3083561806C2776235491 @default.
• W3083561806 hasConceptScore W3083561806C2778918659 @default.
• W3083561806 hasConceptScore W3083561806C41008148 @default.
• W3083561806 hasConceptScore W3083561806C41625074 @default.
• W3083561806 hasConceptScore W3083561806C502942594 @default.
• W3083561806 hasConceptScore W3083561806C55493867 @default.
• W3083561806 hasConceptScore W3083561806C555283112 @default.
• W3083561806 hasConceptScore W3083561806C71924100 @default.
• W3083561806 hasLocation W30835618061 @default.
• W3083561806 hasOpenAccess W3083561806 @default.
• W3083561806 hasPrimaryLocation W30835618061 @default.
• W3083561806 hasRelatedWork W1527721123 @default.
• W3083561806 hasRelatedWork W2004975012 @default.
• W3083561806 hasRelatedWork W2318428112 @default.
• W3083561806 hasRelatedWork W2560702060 @default.
• W3083561806 hasRelatedWork W2748952813 @default.
• W3083561806 hasRelatedWork W2899084033 @default.
• W3083561806 hasRelatedWork W319057817 @default.
• W3083561806 hasRelatedWork W334808203 @default.
• W3083561806 hasRelatedWork W77534462 @default.
• W3083561806 hasRelatedWork W949967022 @default.
• W3083561806 isParatext "false" @default.
• W3083561806 isRetracted "false" @default.
• W3083561806 magId "3083561806" @default.
• W3083561806 workType "article" @default.